126 related articles for article (PubMed ID: 9681100)
1. Raloxifene provides an alternative for osteoporosis prevention.
Willhite SL; Goebel SR; Scoggin JA
Ann Pharmacother; 1998; 32(7-8):834-7. PubMed ID: 9681100
[No Abstract] [Full Text] [Related]
2. Antiestrogenic action of raloxifene and tamoxifen: today and tomorrow.
Jordan VC
J Natl Cancer Inst; 1998 Jul; 90(13):967-71. PubMed ID: 9665143
[No Abstract] [Full Text] [Related]
3. Encouraging news from the SERM frontier. Selective estrogen receptor modulator.
Franks AL; Steinberg KK
JAMA; 1999 Jun; 281(23):2243-4. PubMed ID: 10376579
[No Abstract] [Full Text] [Related]
4. [Raloxifene].
Hofbauer LC; Heufelder AE
Dtsch Med Wochenschr; 1999 Jan; 124(1-2):19-20. PubMed ID: 9951454
[No Abstract] [Full Text] [Related]
5. Raloxifene: a selective estrogen receptor modulator.
Scott JA; Da Camara CC; Early JE
Am Fam Physician; 1999 Sep; 60(4):1131-9. PubMed ID: 10507743
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene.
Balfour JA; Goa KL
Drugs Aging; 1998 Apr; 12(4):335-41; discussion 342. PubMed ID: 9571395
[TBL] [Abstract][Full Text] [Related]
7. Clinical effects of raloxifene hydrochloride in women.
Khovidhunkit W; Shoback DM
Ann Intern Med; 1999 Mar; 130(5):431-9. PubMed ID: 10068418
[TBL] [Abstract][Full Text] [Related]
8. [Current trends in prevention and therapy of postmenopausal osteoporosis].
Rossi G
Recenti Prog Med; 1998 Jun; 89(6):288. PubMed ID: 9658894
[No Abstract] [Full Text] [Related]
9. Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women.
Nickelsen T; Lufkin EG; Riggs BL; Cox DA; Crook TH
Psychoneuroendocrinology; 1999 Jan; 24(1):115-28. PubMed ID: 10098223
[TBL] [Abstract][Full Text] [Related]
10. [Agonists-antagonists of estrogens, their potential use in prophylaxis and treatment of osteoporosis].
Hoszowski K
Pol Tyg Lek; 1995 Nov; 50(44-47):41-2. PubMed ID: 8643425
[TBL] [Abstract][Full Text] [Related]
11. Raloxifene: designer estrogen for preventing postmenopausal osteoporosis.
Park L; Evans MF
Can Fam Physician; 1999 May; 45():1191-3. PubMed ID: 10349062
[No Abstract] [Full Text] [Related]
12. A new alternative to estrogen: raloxifene.
Runowicz C
Health News; 1998 Jun; 4(8):4. PubMed ID: 9644506
[No Abstract] [Full Text] [Related]
13. Raloxifene: magic bullet for heart and bone?
Gustafsson JA
Nat Med; 1998 Feb; 4(2):152-3. PubMed ID: 9461183
[No Abstract] [Full Text] [Related]
14. Raloxifene-associated hepatitis.
Vilches AR; Pérez V; Suchecki DE
Lancet; 1998 Nov; 352(9139):1524-5. PubMed ID: 9820309
[No Abstract] [Full Text] [Related]
15. [Raloxifene: a new molecule for the prevention of menopausal osteoporosis].
Oliaro A
Minerva Ginecol; 1998 Mar; 50(3):XII-XIII. PubMed ID: 9595915
[No Abstract] [Full Text] [Related]
16. Of designer drugs, magic bullets, and gold standards.
Rifkind BM; Rossouw JE
JAMA; 1998 May; 279(18):1483-5. PubMed ID: 9600485
[No Abstract] [Full Text] [Related]
17. Tamoxifen, raloxifene findings unlikely to encourage genetic screening for breast cancer.
Dove A
Nat Med; 1998 Jun; 4(6):647. PubMed ID: 9623955
[No Abstract] [Full Text] [Related]
18. Gonadal hormone substitutes: effects on the cardiovascular system.
Clarkson TB; Cline JM; Williams JK; Anthony MS
Osteoporos Int; 1997; 7 Suppl 1():S43-51. PubMed ID: 9205646
[No Abstract] [Full Text] [Related]
19. Raloxifene as a multifunctional medicine? Current trials will show whether it is effective in both osteoporosis and breast cancer.
Jordan VC; Morrow M
BMJ; 1999 Aug; 319(7206):331-2. PubMed ID: 10435938
[No Abstract] [Full Text] [Related]
20. Prevention of corticosteroid-induced osteoporosis and fractures.
O'Mahony D
J Clin Pharm Ther; 1999 Apr; 24(2):83-5. PubMed ID: 10380059
[No Abstract] [Full Text] [Related]
[Next] [New Search]
